Altamira Technology Corporation

Altamira Therapeutics is a clinical-stage biopharmaceutical company focused on developing RNA delivery technologies and nasal health products. The company's core technology revolves around its proprietary peptide-based platforms, OligoPhore and SemaPhore, which facilitate the delivery of RNA therapeutics (such as siRNA and mRNA) to extrahepatic tissues. Altamira's portfolio includes Bentrio, a commercial-stage, drug-free nasal spray designed to protect against airborne allergens and viruses. Additionally, the company is advancing a pipeline of RNA-based programs targeting oncology and inflammatory diseases, while seeking to divest or partner its legacy assets in inner ear disorders and mental health.